Barriers to end-of-life discussions among hematologists: A qualitative study

Greer JA Jackson VA Meier DE et al . Early integration of palliative care services with standard oncology care for patients with advanced cancer. CA Cancer J Clin 2013; 63(5): 349–363.

Bakitas MA Tosteson TD Li Z et al . Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 2015; 33(13): 1438–1445.

Temel JS Greer JA Muzikansky A et al . Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363(8): 733–742.

Zimmermann C Swami N Krzyzanowska M et al . Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet Lond Engl 2014; 383(9930): 1721–1730.

LeBlanc TW El-Jawahri A. When and why should patients with hematologic malignancies see a palliative care specialist? Hematol Am Soc Hematol Educ Program 2015; 2015: 471–478.

Howell DA Shellens R Roman E et al . Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? a systematic review and meta-analysis of published data. Palliat Med 2011; 25(6): 630–641.

Manitta VJ Philip JAM Cole-Sinclair MF. Palliative care and the hemato-oncological patient: can we live together? a review of the literature. J Palliat Med 2010; 13(8): 1021–1025.

Adsersen M Thygesen LC Neergaard MA et al . Admittance to specialized palliative care (SPC) of patients with an assessed need: a study from the Danish palliative care database (DPD). Acta Oncol Stockh Swed 2017; 56(9): 1210–1217.

Manitta V Zordan R Cole-Sinclair M et al . The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manage 2011; 42(3): 432–442.

Fadul NA El Osta B Dalal S et al . Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med 2008; 11(3): 422–427.

HMRN. Survival, https://www.hmrn.org/statistics/survival (accessed 4 November 2017).

Hui D Kim S-H Kwon JH et al . Access to palliative care among patients treated at a comprehensive cancer center. The Oncologist 2012; 17(12): 1574–1580.

Auret K Bulsara C Joske D. Australasian haematologist referral patterns to palliative care: lack of consensus on when and why. Intern Med J 2003; 33(12): 566–571.

Epstein AS Goldberg GR Meier DE. Palliative care and hematologic oncology: the promise of collaboration. Blood Rev 2012; 26(6): 233–239.

Cheng W-W Willey J Palmer JL et al . Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med 2005; 8(5): 1025–1032.

LeBlanc TW O’Donnell JD Crowley-Matoka M et al . Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. J Oncol Pract Am Soc Clin Oncol 2015; 11(2): e230–e238.

Odejide OO Salas Coronado DY Watts CD et al . End-of-life care for blood cancers: a series of focus groups with hematologic oncologists. J Oncol Pract Am Soc Clin Oncol 2014; 10(6): e396–e403.

Brown AJ Shen MJ Ramondetta LM et al . Does death anxiety affect end-of-life care discussions? Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 2014; 24(8): 1521–1526.

Wright AA Zhang B Ray A et al . Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008; 300(14): 1665–1673.

Mack JW Cronin A Keating NL et al . Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 2012; 30(35): 4387–4395.

Mack JW Walling A Dy S et al . Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer. Cancer 2015; 121(11): 1891–1897.

Mack JW Weeks JC Wright AA et al . End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol 2010; 28(7): 1203–1208.

Howell D Fitch MI Deane KA. Women’s experiences with recurrent ovarian cancer. Cancer Nurs. Févr 2003; 26(1): 10–17.

Elit LM Charles C Gafni A et al . How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter. Health Expect 2015; 18(5): 1066–1080.

Step MM Ray EB. Patient perceptions of oncologist–patient communication about prognosis: changes from initial diagnosis to cancer recurrence. Health Commun 2011; 26(1): 48–58.

Glaser BG Strauss AL. Awareness of dying. Piscataway, NJ: Transaction Publishers; 1966.

Charmaz K Belgrave LL. Grounded theory. Hoboken, NJ: John Wiley & Sons; 2007.

Tong A Sainsbury P Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19(6): 349–357.

Allen SL Davis KS Rousseau PC et al . Advanced care directives: overcoming the obstacles. J Grad Med Educ 2015; 7(1): 91–94.

Greutmann M Tobler D Colman JM et al . Facilitators of and barriers to advance care planning in adult congenital heart disease. Congenit Heart Dis 2013; 8(4): 281–288.

Curtis JR Patrick DL Caldwell ES et al . Why don’t patients and physicians talk about end-of-life care? barriers to communication for patients with acquired immunodeficiency syndrome and their primary care clinicians. Arch Intern Med 2000; 160(11): 1690–1696.

Broom A Kirby E Good P et al . The troubles of telling: managing communication about the end of life. Qual Health Res 2014; 24(2): 151–162.

Broom A Kirby E Good P et al . The art of letting go: referral to palliative care and its discontents. Soc Sci Med 2013; 78: 9–16.

Daneault S Dion D Sicotte C et al . Hope and noncurative chemotherapies: which affects the other? J Clin Oncol 2010; 28(13): 2310–2313.

Daneault S Lussier V Mongeau S et al . Ultimate journey of the terminally ill: ways and pathways of hope. Can Fam Physician Med Fam Can 2016; 62(8): 648–656.

Dufault K Martocchio BC. Symposium on compassionate care and the dying experience, hope: its spheres and dimensions. Nurs Clin North Am 1985; 20(2): 379–391.

Mack JW Wolfe J Cook EF et al . Hope and prognostic disclosure. J Clin Oncol 2007; 25(35): 5636–5642.

Clayton JM Butow PN Arnold RM et al . Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer 2005; 103(9): 1965–1975.

Hagerty RG, Butow PN, Ellis PM, Dimitry S, Tattersall MHN. Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol Off J Eur Soc Med Oncol ESMO. juill 2005; 16(7): 1005–1053.

Smucker WD Ditto PH Moore KA et al . Elderly outpatients respond favorably to a physician-initiated advance directive discussion. J Am Board Fam Pract 1993; 6(5): 473–482.

Helft PR. Necessary collusion: prognostic communication with advanced cancer patients. J Clin Oncol 2005; 23(13): 3146–3150.

Pfeifer MP Sidorov JE Smith AC et al . The discussion of end-of-life medical care by primary care patients and physicians: a multicenter study using structured qualitative interviews. The EOL Study Group. J Gen Intern Med 1994; 9(2): 82–88.

Christakis NA Lamont EB . Extent and determinants of error in physicians’ prognoses in terminally ill patients: prospective cohort study. West J Med. mai 2000; 172(5): 310–313.